Fluorescence-Guided Surgery—Illuminating the Limits of Cancer Therapeutics

This Viewpoint describes the use of optically labeled therapeutic antibodies in fluorescence-guided surgery to advance understanding of drug delivery in cancer therapy.

Authors

Institutions

Publication Details

Journal
JAMA Surgery
Published
2026-01-28
DOI
https://doi.org/10.1001/jamasurg.2025.6246
Primary Topic
Cancer Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fluorescence-Guided Surgery—Illuminating the Limits of Cancer Therapeutics

Eben L. Rosenthal, Shravan Gowrishankar, Hidenori Tanaka
JAMA Surgery
Cancer Research and Treatments
article

Fluorescence-Guided Surgery—Illuminating the Limits of Cancer Therapeutics

Eben L. Rosenthal, Shravan Gowrishankar, Hidenori Tanaka
article en

Abstract

This Viewpoint describes the use of optically labeled therapeutic antibodies in fluorescence-guided surgery to advance understanding of drug delivery in cancer therapy.

JAMA SurgeryVol. 161(3)
Vanderbilt University Medical Center (US)
Good health and well-being
Openalex Percentile: Top 76%
Cancer Research and Treatments
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.